For more updates follow Grant Thornton Bharat on WhatsApp
Providing M&A and PE deal insights
The evolving macroeconomic landscape and dynamic business environment continually present challenges to large and expanding businesses, especially those with international operations.
Grant Thornton offers a solution with our Dealtracker publication, providing comprehensive deal insights at your fingertips. This publication delivers highlights, sector updates, and in-depth analyses of current opportunities and challenges in the industry.
With nearly two decades of active tracking in PE investment and M&A deal activities, our flagship publication, Dealtracker, remains a reliable source. We emphasise that both these activities will play a pivotal role as the Indian economy aims to regain its high growth trajectory. To achieve this, India Inc. must intensify its focus on both private equity investments, and mergers and acquisitions.
The report features extensive data on VC/PE investments and M&A deal activities, offering insights into industry growth across sectors and companies of various sizes. Our coverage is comprehensive, capturing deals within the Indian territory and providing timely reports that offer an overview of deal sentiment in India.
Our suite of coverage includes:
India's real estate industry recorded stronger transaction activity during the quarter. Domestic activity, capital market fundraising and investor interest in income-generating assets continued to support market activity.
The consumer and retail sector witnessed sustained investment interest as businesses strengthened category leadership, expanded portfolios and pursued differentiated growth opportunities.
The April edition of the Monthly Dealtracker presents a consolidated view of transaction activity across mergers and acquisitions, private equity and public markets.
India’s dealmaking environment continued to demonstrate resilience in May 2026, supported by sustained activity across mergers and acquisitions, private equity, and public markets.
The April edition of the Monthly Dealtracker presents a consolidated view of transaction activity across mergers and acquisitions, private equity and public markets.
Pharma and healthcare deal activity in Q1 2026 reflects steady volumes alongside a more measured approach to capital deployment.